Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum
Authors:
- 1 August 2008
- journal article
- case report
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 67 (8) , 1181-1183
Abstract
Rarely, tumour necrosis factor (TNF)α antagonist therapy has been associated with de novo psoriasiform eruptions. This is unusual in that these same drugs are used to treat psoriasis. Most of these cases involve the palms and soles, yet palmoplantar pustular psoriasis represents only 1.7% of all cases of psoriasis. Keratoderma blenorrhagicum is a psoriasiform rash that occurs primarily on the palms and soles of some patients with reactive arthritis. It is grossly and histologically indistinguishable from pustular psoriasis. Chlamydia trachomatis is a common aetiological agent for reactive arthritis, and in vitro studies have shown that chlamydial replication is inversely proportional to TNFα levels. Three patients taking TNFα antagonists are presented who developed such lesions and who were found to be positive for C trachomatis DNA in the affected skin. It is proposed that these psoriasiform lesions may not be psoriasis, but rather keratoderma blenorrhagicum.Keywords
This publication has 9 references indexed in Scilit:
- A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agentsAnnals of the Rheumatic Diseases, 2006
- Reactive Arthritis: Defined Etiologies, Emerging Pathophysiology, and Unresolved TreatmentInfectious Disease Clinics of North America, 2006
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Early cytokine profiles in the joint define pathogen clearance and severity of arthritis in Chlamydia‐induced arthritis in ratsArthritis & Rheumatism, 2006
- Psoriasis induced by anti–tumor necrosis factor therapy: A paradoxical adverse reactionArthritis & Rheumatism, 2005
- Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective studyArthritis Research & Therapy, 2005
- Inhibition of chlamydia trachomatis growth by human interferon-.ALPHA.: mechanisms and synergistic effect with interferon-.GAMMA. and tumor necrosis factor-.ALPHA.Biomedical Research, 2005
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Chlamydia and associated arthritisCurrent Opinion in Rheumatology, 2000